Welcome to the international HTA database

Showing [23369 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2014	HAYES, Inc.	Positron Emission Tomography (PET) for metastatic melanoma
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Rotigotine (Neupro - UCB Canada Inc.) indication: idiopathic Parkinson disease (early and advanced)
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Obinutuzumab (Gazyva®) for previously untreated patients with chronic lymphocytic leukaemia (CLL)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Anesthetic injections into the stellate ganglion for the treatment of hot flashes in women: a review of clinical and cost-effectiveness and guidelines
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	The use of teledermatology and teledermoscopy for referrals of patients with suspected skin cancer
2014	NIHR Health Technology Assessment programme	Prospective multicentre randomised, double-blind, equivalence study comparing clonidine and midazolam as intravenous sedative agents in critically ill children: the SLEEPS (Safety profiLe, Efficacy and Equivalence in Paediatric intensive care Sedation) study
2014	HAYES, Inc.	Robotically assisted hysterectomy
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Magnetic resonance imaging for patients with surgically implanted devices: safety and guidelines
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Endobronchial valves in emphysema]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimal oxygen saturation range for adults suffering from traumatic brain injury: a review of patient benefit, harms, and guidelines
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Miethke proSA® adjustable gravitational shunt for hydrocephalus
2014	The Regional Health Technology Assessment Centre (HTA-centrum)	Hemodialysis twice versus three times a week in patients with residual kidney function: quality of life, cardiovascular outcomes and mortality
2014	HAYES, Inc.	Sensory integration therapy for non-autistic children
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fentanyl transdermal patches in palliative care: clinical effectiveness, safety, and guidelines
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Implantation of a permanent embolic protection in patients with non-valvular attrial fibrillation in left auricular appendage]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Junctional tourniquets for controlling hemorrhage from wounds in adults: a review of clinical effectiveness, cost-effectiveness, safety, and guidelines
2014	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Drug-eluting stents with CD34 antibodies for the treatment of coronary artery disease
2014	HAYES, Inc.	Smoking cessation in patients with schizophrenia
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Electric shocks from conducted electric weapons: long-term clinical effects and guidelines for medical follow-up
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Stereotactic radiofrequency / SRFA SRFA in hepatocellular carcinoma and liver metastases]
2014	NIHR Health Technology Assessment programme	KRAS mutation testing of tumours in adults with metastatic colorectal cancer: a systematic review and cost-effectiveness analysis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Antiemetics for adults experiencing opioid-induced nausea: a review of clinical and cost-effectiveness, benefits and harms, and guidelines
2014	HAYES, Inc.	The use of Information Communication Technology (ICT) to improve treatment adherence in patients with diabetes
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Balloon gastrostomy devices for adults: guidelines for replacement, maintenance, and training
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Hyperthermic intraperitoneal chemotherapy]
2014	NIHR Health Services and Delivery Research programme	A cross-sectional prevalence survey of psychotropic medication prescribing patterns in prisons in England
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Hearing protection fit testing systems: clinical and cost-effectiveness and guidelines
2014	HAYES, Inc.	Transcranial direct current stimulation for depression
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Oral intake in critical care patients: guidelines and recommendations
2014	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	[Percutaneous transluminal angioplasty (pta) with drug eluting stents in peripheral arterial disease, upper limb and thorax]
2014	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Islet transplantation in patients with Type 1 Diabetes Mellitus
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Positive expiratory pressure devices and incentive spirometers for the prevention of pneumonia: comparative clinical effectiveness and guidelines
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Pharmacologic and non-pharmacologic treatments for alcohol withdrawal in the outpatient setting: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2014	HAYES, Inc.	Transcranial magnetic stimulation for treatment-resistant depression
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Capnography and/or oximetry monitoring of patients using patient-controlled intravenous opioids: clinical and cost-effectiveness, safety, and guidelines
2014	NIHR Health Technology Assessment programme	Clinical effectiveness of interventions for treatment-resistant anxiety in older people: a systematic review
2014	Technology Assessment Unit of the McGill University Health Centre (MUHC)	Excimer laser atherectomy for uncrossable coronary lesions and improperly deployed coronary stents
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Use of chlorhexidine gluconate with alcohol for the prevention of peripheral intravenous device infections: a review of clinical and cost effectiveness, and guidelines
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Long-term sustained clinical remission after stopping first-line anti-TNF agents in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis: clinical effectiveness
2014	NIHR Health Technology Assessment programme	A systematic review of the effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia
2014	HAYES, Inc.	Transcranial Magnetic Stimulation (TMS) to enhance pharmacotherapy for depression
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dehumidifiers for reduction of humidity in operating rooms: clinical effectiveness and guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Options for developing a web-based forum on patient registries
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening tools to identify adults with cognitive impairment associated with a neurological impairment: diagnostic accuracy
2014	NIHR Health Technology Assessment programme	Systematic review to identify and appraise outcome measures used to evaluate childhood obesity treatment interventions (CoOR): evidence of purpose, application, validity, reliability and sensitivity
2014	HAYES, Inc.	Afirma thyroid FNA analysis
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	KRAS testing for metastatic colorectal cancer using therascreen KRAS RGQ PCR kit
2014	Agency for Healthcare Research and Quality (AHRQ)	Transition care for children with special health needs
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Naloxone prescribing: guidelines
2014	HAYES, Inc.	ERCC1 expression analysis in Non-Small Cell Lung Cancer (NSCLC)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Aclidinium bromide (Tudorza Genuair - Almirall Canada Ltd.) indication: chronic obstructive pulmonary disease
2014	Agency for Healthcare Research and Quality (AHRQ)	Outcome measure framework design document
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Developmental effects of in utero exposure to prescription drug abuse in infants and young children: harms
2014	HAYES, Inc.	HERmark breast cancer assay
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	High-fidelity simulation training for health care professionals: cost effectiveness and guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Safety of vaccines used for routine immunization in the United States
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Slow-release opioids for postoperative pain: clinical effectiveness
2014	HAYES, Inc.	Immunoglobulin gene testing for B-cell leukemia
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Appropriate use of hand-held wireless devices in healthcare settings: guidelines
2014	Agency for Healthcare Research and Quality (AHRQ)	Antidepressant treatment of depression during pregnancy and the postpartum period
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Prolotherapy for the management of musculoskeletal pain: a review of the clinical effectiveness
2014	NIHR Health Technology Assessment programme	Vitamin D supplementation in pregnancy: a systematic review
2014	HAYES, Inc.	L1 syndrome (L1CAM-related disorders)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bivalirudin infusion following angioplasty: safety
2014	Agency for Healthcare Research and Quality (AHRQ)	Decision aids for advance care planning
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Brain electrical activity mapping for diagnosing psychiatric disorders: a review of the clinical evidence
2014	German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI)	[Systematic guideline search and appraisal, as well as extraction of relevant recommendations, for the DMP "asthma"]
2014	HAYES, Inc.	PTEN gene expression testing in Non-Small Cell Lung Cancer (NSCLC)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Rivaroxaban (Xarelto- Bayer Inc.) new Indication: pulmonary embolism
2014	Agency for Healthcare Research and Quality (AHRQ)	Therapies for children with autism spectrum disorder: behavioral interventions update
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Aripiprazole for pregnant women: safety
2014	HAYES, Inc.	Von Hippel-Lindau (VHL) syndrome
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Golimumab (Simponi - Janssen Inc.) new indication: ulcerative colitis
2014	Agency for Healthcare Research and Quality (AHRQ)	Cardiac troponins used as diagnostic and prognostic tests in patients with kidney disease
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Neuro-linguistic programming for the treatment of adults with post-traumatic stress disorder, general anxiety disorder, or depression: a review of clinical effectiveness and guidelines
2014	HAYES, Inc.	Apnea Risk Evaluation System (ARES; Watermark Medical Inc.) for diagnosis of obstructive sleep apnea
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Nebulizers for the methacholine challenge test: diagnostic accuracy and guidelines
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Stereotactic ablative radiation therapy for the treatment of non-small cell lung cancer]
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Locked units to limit access for dementia patients in long-term care facilities: clinical evidence
2014	HAYES, Inc.	ATI neurostimulation system (Autonomic Technologies Inc.) for electrical stimulation of the Sphenopalatine Ganglion (SPG) for headache
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Intra-aortic balloon pumps for cardiac conditions: guidelines
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Digital Breast Tomosynthesis]
2014	Medical Services Advisory Committee (MSAC)	Insertion of subcutaneous electrode for the purpose of use with an implantable cardioverter defibrillator (ICD)
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcranial magnetic stimulation for the treatment of adults with PTSD, GAD, or depression: a review of clinical effectiveness and guidelines
2014	HAYES, Inc.	Catalys precision laser system (OptiMedica Corp.; Abbott Medical Optics) for cataract surgery
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Sterilization of gauze for surgical procedures: clinical effectiveness, harms, and guidelines
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Effectiveness and safety of single-use protective sheaths for flexible nasopharyngolaryngoscopes]
2014	Medical Services Advisory Committee (MSAC)	Ocriplasmin for symptomatic vitreomacular adhesion (sVMA) including macular hole
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening and risk stratification for diabetic foot ulcers: a review of clinical effectiveness, cost-effectiveness, and guidelines
2014	NIHR Health Technology Assessment programme	The design of a survey questionnaire to measure perceptions and behaviour during an influenza pandemic: the Flu TElephone Survey Template (FluTEST)
2014	HAYES, Inc.	iFuse implant system (SI-BONE Inc.) for sacroiliac joint fusion for treatment of low back pain
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Personal protection for visitors to patients on airborne precautions: clinical effectiveness and guidelines
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Use of Fertil ProMD products in the treatment of infertility]
2014	Medical Services Advisory Committee (MSAC)	Specialist dermatology services delivered by asynchronous store and forward technology
2014	HAYES, Inc.	Inhaled nitric oxide for Acute Respiratory Distress Syndrome (ARDS) in adults
2014	Canadian Agency for Drugs and Technologies in Health (CADTH)	Tocilizumab (Actemra - Hoffmann-La Roche Limited) new indication: polyarticular juvenile idiopathic arthritis
2014	Institut national d'excellence en sante et en services sociaux (INESSS)	[Lung cancer: investigation, treatment and follow-up algorithms]
2014	HAYES, Inc.	Applied behavior analysis-based interventions for autism spectrum disorder
2014	Medical Services Advisory Committee (MSAC)	Transcatheter occlusion of the left atrial appendage (LAA) for patients with non-valvular atrial fibrillation
2014	NIHR Health Technology Assessment programme	Multicentre cluster randomised trial comparing a community group exercise programme and home-based exercise with usual care for people aged 65 years and over in primary care